Evaluating Safety in Insulin-Requiring Diabetic Patients Receiving Inavolisib Plus Endocrine Therapy-Based Regimens in the Real World First published 01/10/2026 Last updated 01/10/2026 EU PAS number:EUPAS1000001124 Study Planned